It is clear to me that you are either being paid by Endonovo for marketing or some form of promotional job because there is no way anyone in the world a spin-off could happen here.
If you think Endonovo can spin-off or start a new business and the debt would leave Endonovo and go into another business you are sadly mistaken. It doesn't work like that. There are accounting issues, legal issues that do not allow for that to happen because there are tax implications. there are NOL's (net operating losses) that must be held within a company to receive future tax breaks, there are other reasons and a transfer of debt from one entity to another entity controlled by Alan Collier can not happen.
I will give you another thing you are so wrong about - it is sad is that Sofpulse is misleading people by claiming it is securing EU and Asia rights. Sofpulse had no sales here in the United States meanwhile over the last 7+ years Endonovo has issued press releases about distribution agreements with multiple companies, none of which generated any sales. Endonovo has hired many executives with so called great resumes and bio's to lead the sales here in the U.S., none of which generated any sales.
Now they are going internationally? You claim it is a REVOLUTIONARY PRODUCT, what makes it revolutionary. There are no sales. Avivi couldn't make a go of it. Alan Collier couldn't make a go of it. Now the new thing to raise capital is to do a spin off and go internationally.
You will probably claim it is revolutionary because it fights the opioid pandemic. It has done nothing against the opioid problem here in the U.S. or anywhere because there is no sales.
It is Sad that people bought into this entire story from day one and all that has been accomplished is Alan Collier has paid himself a salary on the backs of unsophisticated investors.
